Last reviewed · How we verify
NCT06709911: TGCT
A Comparative Study of the Efficacy of Multimodal Interventions for Tenosynovitis
NA trial testing Basic Manipulation Stretching in TGCT in 45 participants. Not yet recruiting.
1 March 2025
Quick facts
| Lead sponsor | Zixin Deng |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 1 December 2024 |
| Primary completion | 1 March 2025 |
| Estimated completion | 1 April 2025 |
Drugs / interventions tested
- Basic Manipulation Stretching
- Massage and Tui Na Manipulation
- Blood flow restriction training
- Magnetic Bead Pressure Stimulation and Tui Na Manipulation Combined Intervention
Conditions studied
- TGCT — all drugs for TGCT →
Sponsor
Zixin Deng
Who can join
Adults 18 to 60, any sex, with TGCT. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare the efficacy of four treatments in patients with hand tenosynovitis. The main questions it aims to answer are: Which treatment most effectively reduces pain and improves joint function? How do the treatments differ in improving strength and range of motion? Researchers will compare four groups-basic manipulation, tui na manipulation, blood flow restriction (BFR) training, and magnetic bead application combined with tui na-to see if there are differences in clinical outcomes. Participants will: Be randomly assigned to one of the four treatment groups. Receive interventions twice a week for 4-8 weeks. Undergo assessments of pain, function, range of motion, and strength before, during, and after the treatment period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06709911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for TGCT
Currently open trials in the same condition.
- NCT05417789 — Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) · Phase 3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06709911 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zixin Deng
- Last refreshed: 3 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06709911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing